• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精英控制者的脑脊液和血浆配对样本中 HIV-1 RNA 的单拷贝 assay 定量分析。

Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers.

机构信息

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet and Swedish Institute for Communicable Disease Control, Stockholm, Sweden.

出版信息

AIDS. 2013 Apr 24;27(7):1145-9. doi: 10.1097/QAD.0b013e32835cf235.

DOI:10.1097/QAD.0b013e32835cf235
PMID:23211774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4004626/
Abstract

OBJECTIVE

Elite controllers are a rare subset of HIV-1-infected individuals who maintain HIV-1 RNA concentrations in plasma below the lower limit of quantification of clinical assays (<20-50 copies/ml) in the absence of antiretroviral therapy. Here, we examine to what extent elite controllers also control infection of the central nervous system (CNS).

DESIGN

We analysed paired cerebrospinal fluid (CSF) and plasma samples using a highly sensitive assay for HIV-1 RNA quantification.

METHODS

We analysed 28 CSF samples and 27 concurrent plasma samples from 14 elite controllers with the highly sensitive single-copy assay (SCA) that allows for HIV-1 RNA quantification down to less than one copy of HIV-1 RNA per millilitre.

RESULTS

Three samples were excluded because of internal standard failure. HIV-1 RNA was detected in only five of 26 CSF samples compared with 14 of 26 plasma samples (P = 0.02), with a median of 0.2 (range, 0.1-6) copies/ml in CSF compared with 0.8 (range, 0.1-189 copies/ml) in plasma (P < 0.0001).

CONCLUSION

HIV-1 RNA could not be detected in CSF in most elite controllers using the highly sensitive SCA, and when detected, it was at significantly lower frequencies and concentrations than in plasma. Elite controllers thus control HIV-1 in the CNS very well. Whether the infrequent and small amounts of HIV-1 RNA in the CSF reflect production from a local reservoir or virion exchange between the blood and the CSF is uncertain.

摘要

目的

精英控制者是 HIV-1 感染者中的一个罕见亚群,他们在未接受抗逆转录病毒治疗的情况下,血浆中 HIV-1 RNA 浓度低于临床检测的下限(<20-50 拷贝/ml)。在这里,我们研究精英控制者在多大程度上也能控制中枢神经系统(CNS)的感染。

设计

我们使用一种高度敏感的 HIV-1 RNA 定量检测方法分析了配对的脑脊液(CSF)和血浆样本。

方法

我们用高度敏感的单拷贝检测法(SCA)分析了 14 名精英控制者的 28 份 CSF 样本和 27 份同期血浆样本,该检测法可检测到每毫升少于 1 拷贝的 HIV-1 RNA。

结果

由于内标失败,有 3 个样本被排除在外。与 26 份血浆样本中的 14 份相比,只有 5 份 CSF 样本中检测到 HIV-1 RNA(P = 0.02),CSF 中的中位数为 0.2(范围,0.1-6)拷贝/ml,而血浆中的中位数为 0.8(范围,0.1-189)拷贝/ml(P < 0.0001)。

结论

使用高度敏感的 SCA,大多数精英控制者的 CSF 中无法检测到 HIV-1 RNA,当检测到 HIV-1 RNA 时,其频率和浓度明显低于血浆。因此,精英控制者很好地控制了中枢神经系统中的 HIV-1。CSF 中 HIV-1 RNA 的数量很少且不频繁是否反映了局部储库的产生或血液与 CSF 之间的病毒粒子交换尚不确定。

相似文献

1
Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers.精英控制者的脑脊液和血浆配对样本中 HIV-1 RNA 的单拷贝 assay 定量分析。
AIDS. 2013 Apr 24;27(7):1145-9. doi: 10.1097/QAD.0b013e32835cf235.
2
Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.HIV 病毒控制者和非控制者脑脊液中的免疫激活与 HIV 特异性 CD8(+) T 细胞
AIDS Res Hum Retroviruses. 2016 Aug;32(8):791-800. doi: 10.1089/AID.2015.0313. Epub 2016 May 2.
3
HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital.巴西一家艾滋病参考医院中脑脊液和血浆中的HIV-1 RNA水平及其与机会性神经系统疾病的相关性
Arq Neuropsiquiatr. 2005 Dec;63(4):907-13. doi: 10.1590/s0004-282x2005000600001. Epub 2005 Dec 15.
4
Analysis of correlation between cerebrospinal fluid and plasma HIV-1 RNA levels in patients with neurological opportunistic diseases.神经系统机会性疾病患者脑脊液与血浆中HIV-1 RNA水平的相关性分析
Rev Inst Med Trop Sao Paulo. 2011 Jul-Aug;53(4):193-6. doi: 10.1590/s0036-46652011000400003.
5
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.未治疗的 HIV-1 感染、中枢神经系统损伤和病毒抑制过程中脑脊液炎症的分隔。
PLoS One. 2021 May 13;16(5):e0250987. doi: 10.1371/journal.pone.0250987. eCollection 2021.
6
Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.抗逆转录病毒治疗期间脑脊液中 HIV RNA 浓度的相关因素:一项纵向队列研究。
Lancet HIV. 2019 Jul;6(7):e456-e462. doi: 10.1016/S2352-3018(19)30143-2. Epub 2019 Jun 14.
7
Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.在长达10年的抑制性治疗后,脑脊液中检测到的低水平HIV-1 RNA与局部免疫激活有关。
AIDS. 2014 Sep 24;28(15):2251-8. doi: 10.1097/QAD.0000000000000400.
8
Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.脑脊液单核细胞计数会影响脑脊液中HIV-1 RNA水平。
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):214-9. doi: 10.1097/00042560-199803010-00005.
9
Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.在高效抗逆转录病毒治疗(HAART)时代,影响有无机会性神经疾病患者脑脊液和血浆中HIV-1 RNA检测率的因素
BMC Infect Dis. 2007 Dec 21;7:147. doi: 10.1186/1471-2334-7-147.
10
Rapid development of HIV elite control in a patient with acute infection.急性感染患者中 HIV 精英控制的快速发展。
BMC Infect Dis. 2019 Sep 18;19(1):815. doi: 10.1186/s12879-019-4374-8.

引用本文的文献

1
Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.未经治疗和治疗的慢性 HIV-1 感染患者脑脊液蛋白谱的变化。
PLoS Pathog. 2024 Sep 24;20(9):e1012470. doi: 10.1371/journal.ppat.1012470. eCollection 2024 Sep.
2
Multimodal Investigation of Neuroinflammation in Aviremic Patients With HIV on Antiretroviral Therapy and HIV Elite Controllers.抗逆转录病毒治疗的无病毒血症 HIV 患者和 HIV 精英控制者的神经炎症的多模态研究。
Neurol Neuroimmunol Neuroinflamm. 2022 Feb 9;9(2). doi: 10.1212/NXI.0000000000001144. Print 2022 Mar.
3
Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection.为何 HIV 储存库不会枯竭:克隆扩增和受 HIV 感染细胞的特征对治愈和控制 HIV 感染的策略提出挑战。
Viruses. 2021 Dec 14;13(12):2512. doi: 10.3390/v13122512.
4
HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity.HIV-1 病毒“闪烁”与反复出现的、且逐渐升高的细胞相关 HIV-1 RNA 转录活性有关。
AIDS. 2021 Nov 1;35(13):2095-2103. doi: 10.1097/QAD.0000000000003001.
5
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.未治疗的 HIV-1 感染、中枢神经系统损伤和病毒抑制过程中脑脊液炎症的分隔。
PLoS One. 2021 May 13;16(5):e0250987. doi: 10.1371/journal.pone.0250987. eCollection 2021.
6
Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance.HIV-1 感染中的带状疱疹:CSF 白细胞增多在继发性 CSF 逃逸和不一致中的作用。
PLoS One. 2020 Jul 22;15(7):e0236162. doi: 10.1371/journal.pone.0236162. eCollection 2020.
7
Markers of CNS Injury in Adults Living With HIV With CSF HIV Not Detected vs Detected <20 Copies/mL.脑脊液中未检测到HIV与检测到HIV但低于20拷贝/毫升的成年HIV感染者的中枢神经系统损伤标志物
Open Forum Infect Dis. 2019 Dec 14;6(12):ofz528. doi: 10.1093/ofid/ofz528. eCollection 2019 Dec.
8
Microglial Cells: The Main HIV-1 Reservoir in the Brain.小胶质细胞:大脑中的 HIV-1 主要储存库。
Front Cell Infect Microbiol. 2019 Oct 24;9:362. doi: 10.3389/fcimb.2019.00362. eCollection 2019.
9
ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial.HIV 阳性且病毒载量低的患者中抗逆转录病毒治疗开始时间的 ART :来自 START 试验的结果。
J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):456-462. doi: 10.1097/QAI.0000000000002052.
10
Single-molecule techniques to quantify and genetically characterise persistent HIV.单分子技术定量和遗传表征持续性 HIV。
Retrovirology. 2018 Jan 9;15(1):3. doi: 10.1186/s12977-017-0386-x.

本文引用的文献

1
Towards an HIV cure: a global scientific strategy.迈向艾滋病治愈:全球科学策略。
Nat Rev Immunol. 2012 Jul 20;12(8):607-14. doi: 10.1038/nri3262.
2
Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy.强化拉替拉韦治疗并未改变抑制性治疗患者的脑脊液 HIV-1 感染或免疫激活。
J Infect Dis. 2011 Dec 15;204(12):1936-45. doi: 10.1093/infdis/jir667. Epub 2011 Oct 21.
3
HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.HIV-1 在具有天然 HIV 感染控制能力的患者中继续复制和进化。
J Virol. 2010 Dec;84(24):12971-81. doi: 10.1128/JVI.00387-10. Epub 2010 Oct 6.
4
Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.在 HIV 精英控制者中,HIV 从激活的 CD4(+) T 细胞中罕见恢复,但外源性感染却很强劲。
Clin Infect Dis. 2010 Jul 15;51(2):233-8. doi: 10.1086/653677.
5
Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.精英控制者体内尽管存在持续的血浆病毒复制和演变,但仍能控制 HIV-1。
J Virol. 2010 Jul;84(14):7018-28. doi: 10.1128/JVI.00548-10. Epub 2010 May 5.
6
Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation.HIV-1 系统病毒控制器中的脑脊液:缺乏 HIV-1 RNA 和鞘内炎症。
AIDS. 2010 Apr 24;24(7):1001-5. doi: 10.1097/QAD.0b013e328331e15b.
7
Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?原发性HIV感染期间病毒复制的自发控制:“HIV控制者”状态何时确立?
Clin Infect Dis. 2009 Sep 15;49(6):982-6. doi: 10.1086/605504.
8
Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.HIV-1精英控制者的持续性低水平病毒血症及其与免疫参数的关系。
J Infect Dis. 2009 Sep 15;200(6):984-90. doi: 10.1086/605446.
9
Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.法国医院HIV数据库中长期无进展者和HIV控制者患者的患病率及比较特征。
AIDS. 2009 Jun 1;23(9):1163-9. doi: 10.1097/QAD.0b013e32832b44c8.
10
Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.在未接受抗逆转录病毒治疗的情况下控制人类免疫缺陷病毒的个体中存在持续性低水平病毒血症的证据。
J Virol. 2009 Jan;83(1):329-35. doi: 10.1128/JVI.01763-08. Epub 2008 Oct 22.